J&J buys into Achillion's hep C pipeline for up to $1.1B
May 19, 2015 | By Damian Garde
Johnson & Johnson ($JNJ), fighting to keep up with the blockbuster race to launch quick cures for hepatitis C, has agreed to pay as much as $1.1 billion for the rights to Achillion Pharmaceuticals' ($ACHN) pipeline of antiviral treatments.
Under the deal, J&J is making a $225 million investment in its partner and promising up to $905 million in milestone payments in order to get its hands on a group of in-development hep C treatments. The plan is to develop Achillion's drugs in combination with one another and, ideally, come up with a regimen thatcan cure the infection in as few as four weeks. Leading the pipeline is ACH-3102, Achillion's Phase II NS5A inhibitor, followed by the complementary ACH-3422 and sovaprevir.
cnbc analyst as all others saying never heard of chardin lol. Bought
Why This Data Is Making Puma Biotechnology, Inc Shares Collapse
By Todd Campbell | More Articles
May 14, 2015 | Comments (0)
What: Shares in Puma Biotechnology (NYSE: PBYI ) collapsed by more than 15% earlier today after abstracts to be presented at the upcoming American Society of Clinical Oncology meeting were released.So What: The abstracts include data on Puma Biotechnology's neratinib, or PB272, a cancer-fighting drug that is the company's lead product candidate.
pretty much a no brainer
AVEO Pharmaceuticals (AVEO) Climbs On Positive Data
by Joshua Rodriguez | Asset News, Biotech, Investing
Asset News, Biotech, Investing
We expect to see more gains. AVEO recently sought FDA guidance with regard to this specific study, and things seem to be going as planned. So, I’m expecting more good news about tivozanib. However,even outside of tivozanib, I’m impressed with the company. AVEO Pharmaceuticals continues to work in an effort to expand their pipeline of candidates and improve upon the candidates they currently have. I’m expecting that tivozanib will find approval and that AVEO Pharmaceuticals willcontinue to work to achieve approval for more and more treatments. All in all, this should lead to gains in the stock
Picks FireEye ( FEYE ) as one of the best growth stocks in 2015
on Twitter tonight
Fitbit is bringing its fitness wearables to India
Kunal Sehgal & Maria Thomas
The world’s largest wearables company is coming to India.
Founded in 2007, Fitbit commands 85% of the global health wearables market Demand for wearables is surging around the world, with shipments expected to jump 173% this year, according to a report byresearch firm IDC.San Francisco-headquartered Fitbit will partner with e-commerce firm Amazon to offerf our types of wearable bands to help Indian consumers track their fitness